{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Alzheimer\u2019s disease", "Ayurvedic herbs", "acetylcholinesterase", "acetylcholinesterase inhibitors", "amyloid beta", "cognition", "neurodegenerative disorders", "tau protein", "traditional medicine"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "38784601", "DateRevised": {"Year": "2024", "Month": "05", "Day": "25"}, "Article": {"Language": ["eng"], "ELocationID": ["10.2147/DNND.S452009"], "ArticleDate": [{"Year": "2024", "Month": "05", "Day": "19"}], "Journal": {"ISSN": "1179-9900", "JournalIssue": {"Volume": "14", "PubDate": {"Year": "2024"}}, "Title": "Degenerative neurological and neuromuscular disease", "ISOAbbreviation": "Degener Neurol Neuromuscul Dis"}, "ArticleTitle": "Review of Pharmacotherapeutic Targets in Alzheimer's Disease and Its Management Using Traditional Medicinal Plants.", "Pagination": {"StartPage": "47", "EndPage": "74", "MedlinePgn": "47-74"}, "Abstract": {"AbstractText": ["Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by cognitive decline, memory loss, and impaired daily functioning. While there is currently no cure for AD, several pharmacotherapeutic targets and management strategies have been explored. Additionally, traditional medicinal plants have gained attention for their potential role in AD management. Pharmacotherapeutic targets in AD include amyloid-beta (A\u03b2) aggregation, tau protein hyperphosphorylation, neuroinflammation, oxidative stress, and cholinergic dysfunction. Traditional medicinal plants, such as <i>Ginkgo biloba, Huperzia serrata, Curcuma longa</i> (turmeric), and Panax ginseng, have demonstrated the ability to modulate these targets through their bioactive compounds. <i>Ginkgo biloba</i>, for instance, contains flavonoids and terpenoids that exhibit neuroprotective effects by reducing A\u03b2 deposition and enhancing cerebral blood flow. <i>Huperzia serrata</i>, a natural source of huperzine A, has acetylcholinesterase-inhibiting properties, thus improving cholinergic function. <i>Curcuma longa</i>, enriched with curcumin, exhibits anti-inflammatory and antioxidant effects, potentially mitigating neuroinflammation and oxidative stress. Panax ginseng's ginsenosides have shown neuroprotective and anti-amyloidogenic properties. The investigation of traditional medicinal plants as a complementary approach to AD management offers several advantages, including a lower risk of adverse effects and potential multi-target interactions. Furthermore, the cultural knowledge and utilization of these plants provide a rich source of information for the development of new therapies. However, further research is necessary to elucidate the precise mechanisms of action, standardize preparations, and assess the safety and efficacy of these natural remedies. Integrating traditional medicinal-plant-based therapies with modern pharmacotherapies may hold the key to a more comprehensive and effective approach to AD treatment. This review aims to explore the pharmacotherapeutic targets in AD and assess the potential of traditional medicinal plants in its management."], "CopyrightInformation": "\u00a9 2024 Tripathi et al."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh, India."}], "LastName": "Tripathi", "ForeName": "Prabhash Nath", "Initials": "PN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh, India."}], "LastName": "Lodhi", "ForeName": "Ankit", "Initials": "A"}, {"Identifier": ["0000-0001-8418-9549"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India."}], "LastName": "Rai", "ForeName": "Sachchida Nand", "Initials": "SN"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh, India."}], "LastName": "Nandi", "ForeName": "Nilay Kumar", "Initials": "NK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh, India."}], "LastName": "Dumoga", "ForeName": "Shweta", "Initials": "S"}, {"Identifier": ["0000-0002-7637-9745"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Meerut, Uttar Pradesh, India."}], "LastName": "Yadav", "ForeName": "Pooja", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Sciences, College of Pharmacy, University of Arkansas for Medical Sciences, Little Rock, AR, 72205, USA."}], "LastName": "Tiwari", "ForeName": "Amit Kumar", "Initials": "AK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Experimental Medicine and Surgery, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India."}], "LastName": "Singh", "ForeName": "Santosh Kumar", "Initials": "SK"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates."}], "LastName": "El-Shorbagi", "ForeName": "Abdel-Nasser A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Medicinal Chemistry, College of Pharmacy, University of Sharjah, Sharjah, United Arab Emirates."}], "LastName": "Chaudhary", "ForeName": "Sachin", "Initials": "S"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "New Zealand", "MedlineTA": "Degener Neurol Neuromuscul Dis", "NlmUniqueID": "101587980", "ISSNLinking": "1179-9900"}, "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Toodayan N. Professor Alois Alzheimer (1864\u20131915): lest we forget. J Clin Neurosci. 2016;31:47\u201355. doi:10.1016/j.jocn.2015.12.032", "ArticleIdList": ["10.1016/j.jocn.2015.12.032", "27312282"]}, {"Citation": "Li X, Feng X, Sun X, Hou N, Han F, Liu Y. Global, regional, and national burden of Alzheimer\u2019s disease and other dementias, 1990\u20132019. Front Aging Neurosci. 2022;14:937486. doi:10.3389/fnagi.2022.937486", "ArticleIdList": ["10.3389/fnagi.2022.937486", "PMC9588915", "36299608"]}, {"Citation": "Th\u00e9baut C, Achille D, Preux P, Guerchet M. Costs of Dementia in Low-And Middle-Income Countries: a Systematic Review. J Alzh Dis. 2022;2022:1.", "ArticleIdList": ["36404540"]}, {"Citation": "Huo Z. The Disease Burden and Economic Cost of Dementia in an Asian Population. Hong Kong: The Chinese University of Hong Kong; 2021."}, {"Citation": "Elfaki BA. Factors contributes to overweight and obesity among young adults; 2023."}, {"Citation": "Ma Y, Ajnakina O, Steptoe A, Cadar D. Higher risk of dementia in English older individuals who are overweight or obese. Internat J Epidemiol. 2020;49(4):1353\u20131365. doi:10.1093/ije/dyaa099", "ArticleIdList": ["10.1093/ije/dyaa099", "PMC7660153", "32575116"]}, {"Citation": "Kabir MT, Shah MA, Alothaim AAS, Al-Ghamdi MS, Rahman MH. Neuroprotective effects of saponins on neurodegenerative diseases. In: Phytonutrients and Neurological Disorders. Elsevier; 2023:259\u2013282."}, {"Citation": "Selman A, Burns S, Reddy AP, Culberson J, Reddy PH. The role of obesity and diabetes in dementia. Internat J Molec Sci. 2022;23(16):9267. doi:10.3390/ijms23169267", "ArticleIdList": ["10.3390/ijms23169267", "PMC9408882", "36012526"]}, {"Citation": "Sathianathan R, Kantipudi SJ. The dementia epidemic: impact, prevention, and challenges for India. Indian J Psych. 2018;60(2):165. doi:10.4103/psychiatry.IndianJPsychiatry_261_18", "ArticleIdList": ["10.4103/psychiatry.IndianJPsychiatry_261_18", "PMC6102955", "30166671"]}, {"Citation": "Ravindranath V, Sundarakumar JS. Changing demography and the challenge of dementia in India. Nat Rev Neurol. 2021;17(12):747\u2013758. doi:10.1038/s41582-021-00565-x", "ArticleIdList": ["10.1038/s41582-021-00565-x", "PMC8522537", "34663985"]}, {"Citation": "Binda A, Murano C, Rivolta I. Innovative therapies and nanomedicine applications for the treatment of Alzheimer\u2019s disease: a state-of-The-art (2017\u20132020). Internat J Nanomed. 2020;15:6113\u20136135. doi:10.2147/IJN.S231480", "ArticleIdList": ["10.2147/IJN.S231480", "PMC7434571", "32884267"]}, {"Citation": "Tarawneh R, Holtzman DM. The clinical problem of symptomatic Alzheimer disease and mild cognitive impairment. Cold Spring Harbor Perspect Med. 2012;2(5):a006148\u2013a006148. doi:10.1101/cshperspect.a006148", "ArticleIdList": ["10.1101/cshperspect.a006148", "PMC3331682", "22553492"]}, {"Citation": "Zubenko GS, Zubenko WN, McPherson S, et al. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer\u2019s disease. Am J Psych. 2003;160(5):857\u2013866. doi:10.1176/appi.ajp.160.5.857", "ArticleIdList": ["10.1176/appi.ajp.160.5.857", "12727688"]}, {"Citation": "Kalia M. Dysphagia and aspiration pneumonia in patients with Alzheimer\u2019s disease. Metabolism. 2003;52:36\u201338. doi:10.1016/S0026-0495(03)00300-7", "ArticleIdList": ["10.1016/S0026-0495(03)00300-7", "14577062"]}, {"Citation": "Sharma P, Srivastava P, Seth A, Tripathi PN, Banerjee AG, Shrivastava SK. Comprehensive review of mechanisms of pathogenesis involved in Alzheimer\u2019s disease and potential therapeutic strategies. Progr Neurobiol. 2019;174:53\u201389. doi:10.1016/j.pneurobio.2018.12.006", "ArticleIdList": ["10.1016/j.pneurobio.2018.12.006", "30599179"]}, {"Citation": "Franchi C, Lucca U, Tettamanti M, et al. Cholinesterase inhibitor use in Alzheimer\u2019s disease: the EPIFARM\u2010Elderly Project. Pharmacoepidemiol Drug Saf. 2011;20(5):497\u2013505. doi:10.1002/pds.2124", "ArticleIdList": ["10.1002/pds.2124", "21432941"]}, {"Citation": "Khan S, Ullah H, Hussain R, et al. Synthesis, in vitro bio-evaluation, and molecular docking study of thiosemicarbazone-based isatin/bis-Schiff base hybrid analogues as effective cholinesterase inhibitors. J Mol Struct. 2023;1284:135351. doi:10.1016/j.molstruc.2023.135351", "ArticleIdList": ["10.1016/j.molstruc.2023.135351"]}, {"Citation": "Srivastava P, Tripathi PN, Sharma P, et al. Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory. Europ J Med Chem. 2019;163:116\u2013135. doi:10.1016/j.ejmech.2018.11.049", "ArticleIdList": ["10.1016/j.ejmech.2018.11.049", "30503937"]}, {"Citation": "Tiwari S, Atluri V, Kaushik A, Yndart A, Nair M. Alzheimer\u2019s disease: pathogenesis, diagnostics, and therapeutics. Internat J Nanomed. 2019;5541\u20135554. doi:10.2147/IJN.S200490", "ArticleIdList": ["10.2147/IJN.S200490", "PMC6650620", "31410002"]}, {"Citation": "Patwardhan B. Ayurveda: the designer medicine. Indian Drugs. 2000;37(5):213\u2013227."}, {"Citation": "Sharma R, Kuca K, Nepovimova E, Kabra A, Rao M, Prajapati P. Traditional Ayurvedic and herbal remedies for Alzheimer\u2019s disease: from bench to bedside. Expert Rev Neurotherap. 2019;19(5):359\u2013374. doi:10.1080/14737175.2019.1596803", "ArticleIdList": ["10.1080/14737175.2019.1596803", "30884983"]}, {"Citation": "Adams M, Gm\u00fcnder F, Hamburger M. Plants traditionally used in age related brain disorders\u2014A survey of ethnobotanical literature. Journal of Ethnopharmacology. 2007;113(3):363\u2013381. doi:10.1016/j.jep.2007.07.016", "ArticleIdList": ["10.1016/j.jep.2007.07.016", "17720341"]}, {"Citation": "Zieneldien T, Kim J, Cao C. The multifaceted role of neuroprotective plants in Alzheimer\u2019s Disease treatment. Geriatrics. 2022;7(2):24. doi:10.3390/geriatrics7020024", "ArticleIdList": ["10.3390/geriatrics7020024", "PMC8938774", "35314596"]}, {"Citation": "Gupta VS, Kale PP. Combinatory Approaches Targeting Cognitive Impairments and Memory Enhancement: a Review. Current Drug Targets. 2023;24(1):55\u201370. doi:10.2174/1389450123666220928152743", "ArticleIdList": ["10.2174/1389450123666220928152743", "36173073"]}, {"Citation": "Wahid M, Ali A, Saqib F, et al. Pharmacological exploration of traditional plants for the treatment of neurodegenerative disorders. Phytoth Res. 2020;34(12):3089\u20133112. doi:10.1002/ptr.6742", "ArticleIdList": ["10.1002/ptr.6742", "32478964"]}, {"Citation": "Singh R, Bhattacharyya C, Prashar V, et al. Tinospora cordifolia: a potential neuroprotective agent against various neurodegenerative diseases. J Herbal Med. 2023;42:100775. doi:10.1016/j.hermed.2023.100775", "ArticleIdList": ["10.1016/j.hermed.2023.100775"]}, {"Citation": "Parihar M, Hemnani T. Alzheimer\u2019s disease pathogenesis and therapeutic interventions. J Clin Neurosci. 2004;11(5):456\u2013467. doi:10.1016/j.jocn.2003.12.007", "ArticleIdList": ["10.1016/j.jocn.2003.12.007", "15177383"]}, {"Citation": "Rai S Nand, Tiwari N, Singh P, et al. Therapeutic potential of vital transcription factors in Alzheimer\u2019s and Parkinson\u2019s disease with particular emphasis on transcription factor EB mediated autophagy. Front Neurosci. 2021;15. doi: 10.3389/fnins.2021.777347", "ArticleIdList": ["10.3389/fnins.2021.777347", "PMC8712758", "34970114"]}, {"Citation": "Ramakrishna K, Nalla LV, Naresh D, et al. WNT-\u03b2 Catenin Signaling as a Potential Therapeutic Target for Neurodegenerative Diseases: Current Status and Future Perspective. Diseases.2023;11(3):89. doi:10.3390/diseases11030089", "ArticleIdList": ["10.3390/diseases11030089", "PMC10366863", "37489441"]}, {"Citation": "T\u00fcrkan F. Investigation of the toxicological and inhibitory effects of some benzimidazole agents on acetylcholinesterase and butyrylcholinesterase enzymes. Arch Physiol Biochem. 2021;127(2):97\u2013101. doi:10.1080/13813455.2019.1618341", "ArticleIdList": ["10.1080/13813455.2019.1618341", "31135232"]}, {"Citation": "Korabecny J, Soukup O. Cholinesterase research. MDPI. 2021;11:1121.", "ArticleIdList": ["PMC8394027", "34439787"]}, {"Citation": "Trang A, Khandhar PB. Physiology, acetylcholinesterase; 2019.", "ArticleIdList": ["30969557"]}, {"Citation": "Kaur A, Anand C, Singh TG, Dhiman S, Babbar R. Acetylcholinesterase inhibitors: a milestone to treat neurological disorders. Plant Arch. 2019;19:1347\u20131359."}, {"Citation": "Mesulam -M-M. The cholinergic innervation of the human cerebral cortex. Prog Brain Res. 2004;145:67\u201378.", "ArticleIdList": ["14650907"]}, {"Citation": "Chen X-Q, Mobley WC. Exploring the pathogenesis of Alzheimer disease in basal forebrain cholinergic neurons: converging insights from alternative hypotheses. Front Neurosci. 2019;13:451499. doi:10.3389/fnins.2019.00446", "ArticleIdList": ["10.3389/fnins.2019.00446", "PMC6514132", "31133787"]}, {"Citation": "Hampel H, Mesulam MM, Cuello AC, et al. Revisiting the cholinergic hypothesis in Alzheimer\u2019s disease: emerging evidence from translational and clinical research. Prevent Alzh Dis. 2019;6:2\u201315. doi:10.14283/jpad.2018.43", "ArticleIdList": ["10.14283/jpad.2018.43", "30569080"]}, {"Citation": "Mesulam MMI. Central cholinergic pathways neuroanatomy and some behavioral implications. Neurotransmitt Cort Funct. 1988;1998:237\u2013260."}, {"Citation": "Geula C, Dunlop SR, Ayala I, et al. Basal forebrain cholinergic system in the dementias: vulnerability, resilience, and resistance. J Neurochem. 2021;158(6):1394\u20131411. doi:10.1111/jnc.15471", "ArticleIdList": ["10.1111/jnc.15471", "PMC8458251", "34272732"]}, {"Citation": "Swaab DF, Kreier F, Lucassen PJ, Salehi A, Buijs RM. The Human Hypothalamus: Anterior Region. Elsevier; 2021."}, {"Citation": "Tripathi PN, Srivastava P, Sharma P, et al. Biphenyl-3-oxo-1, 2, 4-triazine linked piperazine derivatives as potential cholinesterase inhibitors with anti-oxidant property to improve the learning and memory. Bioorg Chem. 2019;85:82\u201396. doi:10.1016/j.bioorg.2018.12.017", "ArticleIdList": ["10.1016/j.bioorg.2018.12.017", "30605887"]}, {"Citation": "Shrivastava SK, Nivrutti AA, Bhardwaj B, et al. Drug reposition-based design, synthesis, and biological evaluation of dual inhibitors of acetylcholinesterase and \u03b2-Secretase for treatment of Alzheimer\u2019s disease. J Mol Struct. 2022;1262:132979. doi:10.1016/j.molstruc.2022.132979", "ArticleIdList": ["10.1016/j.molstruc.2022.132979"]}, {"Citation": "Wright PW. Functional anatomy: types of cells/physiology. Wiley Encycl Health Psychol. 2020;2020:5\u201312."}, {"Citation": "Murugan NA, Pandian CJ, Jeyaseelan JM, et al. Computational development of Alzheimer\u2019s therapeutics and diagnostics; 2021."}, {"Citation": "Ayvazyan NM, O\u2019Leary VB, Dolly JO, Ovsepian SV. Neurobiology and therapeutic utility of neurotoxins targeting postsynaptic mechanisms of neuromuscular transmission. Drug Discovery Today. 2019;24(10):1968\u20131984. doi:10.1016/j.drudis.2019.06.012", "ArticleIdList": ["10.1016/j.drudis.2019.06.012", "31247153"]}, {"Citation": "Walczak-Nowicka \u0141J, Herbet M. Acetylcholinesterase inhibitors in the treatment of neurodegenerative diseases and the role of acetylcholinesterase in their pathogenesis. Internat J Mol Sci. 2021;22(17):9290. doi:10.3390/ijms22179290", "ArticleIdList": ["10.3390/ijms22179290", "PMC8430571", "34502198"]}, {"Citation": "Taha M, Sadia H, Rahim F, et al. Synthesis, biological evaluation and molecular docking study of oxindole based chalcone analogues as potent anti-Alzheimer agents. J MolStruct. 2023;1285:135530. doi:10.1016/j.molstruc.2023.135530", "ArticleIdList": ["10.1016/j.molstruc.2023.135530"]}, {"Citation": "Bacalhau P, San Juan AA, Goth A, Caldeira AT, Martins R, Burke AJ. Insights into (S)-rivastigmine inhibition of butyrylcholinesterase (BuChE): molecular docking and saturation transfer difference NMR (STD-NMR). Bioorg Chem. 2016;67:105\u2013109. doi:10.1016/j.bioorg.2016.06.002", "ArticleIdList": ["10.1016/j.bioorg.2016.06.002", "27317888"]}, {"Citation": "Ramrao SP, Verma A, Waiker DK, Tripathi PN, Shrivastava SK. Design, synthesis, and evaluation of some novel biphenyl imidazole derivatives for the treatment of Alzheimer\u2019s disease. J Molecul Struct. 2021;1246:131152. doi:10.1016/j.molstruc.2021.131152", "ArticleIdList": ["10.1016/j.molstruc.2021.131152"]}, {"Citation": "Jana A, Bhattacharjee A, Das SS, et al. Molecular insights into therapeutic potentials of hybrid compounds targeting Alzheimer\u2019s disease. Molec Neurobiol. 2022;59(6):3512\u20133528. doi:10.1007/s12035-022-02779-6", "ArticleIdList": ["10.1007/s12035-022-02779-6", "PMC9148293", "35347587"]}, {"Citation": "Premkumar T, Sajitha Lulu S. Molecular mechanisms of emerging therapeutic targets in Alzheimer\u2019s disease: a systematic review. Neurochem J. 2022;16(4):443\u2013455. doi:10.1134/S1819712422040183", "ArticleIdList": ["10.1134/S1819712422040183"]}, {"Citation": "Khan S, Ullah H, Taha M, et al. Synthesis, DFT studies, molecular docking and biological activity evaluation of thiazole-sulfonamide derivatives as potent Alzheimer\u2019s inhibitors. Molecules. 2023;28(2):559. doi:10.3390/molecules28020559", "ArticleIdList": ["10.3390/molecules28020559", "PMC9860845", "36677616"]}, {"Citation": "Hussain R, Ullah H, Rahim F, et al. Multipotent cholinesterase inhibitors for the treatment of Alzheimer\u2019s disease: synthesis, biological analysis and molecular docking study of benzimidazole-based thiazole derivatives. Molecules. 2022;27(18):6087. doi:10.3390/molecules27186087", "ArticleIdList": ["10.3390/molecules27186087", "PMC9504419", "36144820"]}, {"Citation": "Jagust WJ, Teunissen CE, DeCarli C. The complex pathway between amyloid \u03b2 and cognition: implications for therapy. The Lancet Neurology. 2023;22(9):847\u2013857. doi:10.1016/S1474-4422(23)00128-X", "ArticleIdList": ["10.1016/S1474-4422(23)00128-X", "37454670"]}, {"Citation": "Hardy J. The amyloid hypothesis for Alzheimer\u2019s disease: a critical reappraisal. J Neurochem. 2009;110(4):1129\u20131134. doi:10.1111/j.1471-4159.2009.06181.x", "ArticleIdList": ["10.1111/j.1471-4159.2009.06181.x", "19457065"]}, {"Citation": "Rai SN, Chaturvedi VK, Singh BK, Singh MP. Commentary: trem2 deletion reduces late-stage amyloid plaque accumulation, elevates the A\u03b242: a\u03b240 ratio, and exacerbates axonal dystrophy and dendritic spine loss in the PS2APP Alzheimer\u2019s mouse model. Front Aging Neurosci. 2020;12:219. doi:10.3389/fnagi.2020.00219", "ArticleIdList": ["10.3389/fnagi.2020.00219", "PMC7461938", "32973484"]}, {"Citation": "Vassar R, Bennett BD, Babu-Khan S, et al. \u03b2-Secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286(5440):735\u2013741. doi:10.1126/science.286.5440.735", "ArticleIdList": ["10.1126/science.286.5440.735", "10531052"]}, {"Citation": "De Ferrari GV, Canales MA, Shin I, Weiner LM, Silman I, Inestrosa NC. A structural motif of acetylcholinesterase that promotes amyloid \u03b2-peptide fibril formation. Biochemistry. 2001;40(35):10447\u201310457. doi:10.1021/bi0101392", "ArticleIdList": ["10.1021/bi0101392", "11523986"]}, {"Citation": "Wu A-G, Zhou X-G, Qiao G, et al. Targeting microglial autophagic degradation in NLRP3 inflammasome-mediated neurodegenerative diseases. Age Res Rev. 2021;65:101202. doi:10.1016/j.arr.2020.101202", "ArticleIdList": ["10.1016/j.arr.2020.101202", "33161129"]}, {"Citation": "Tan M-S, J-T Y, Jiang T, Zhu X-C, Tan L. The NLRP3 inflammasome in Alzheimer\u2019s disease. Molec Neurobiol. 2013;48:875\u2013882. doi:10.1007/s12035-013-8475-x", "ArticleIdList": ["10.1007/s12035-013-8475-x", "23686772"]}, {"Citation": "Andrade-Guerrero J, Santiago-Balmaseda A, Jeronimo-Aguilar P, et al. Alzheimer\u2019s disease: an updated overview of its genetics. Internat J Molec Sci. 2023;24(4):3754. doi:10.3390/ijms24043754", "ArticleIdList": ["10.3390/ijms24043754", "PMC9966419", "36835161"]}, {"Citation": "Escamilla-Ayala A, Wouters R, Sannerud R, Annaert W. Contribution of the Presenilins in the cell biology, structure and function of \u03b3-secretase. Paper presented at: Seminars in cell & developmental biology; 2020.", "ArticleIdList": ["32146031"]}, {"Citation": "Das N, Raymick J, Sarkar S. Role of metals in Alzheimer\u2019s disease. Metab Brain Dis. 2021;36(7):1627\u20131639. doi:10.1007/s11011-021-00765-w", "ArticleIdList": ["10.1007/s11011-021-00765-w", "34313926"]}, {"Citation": "Davidson R, Krider RI, Borsellino P, Noorda K, Alhwayek G, Vida TA. Untangling Tau: molecular Insights into Neuroinflammation, Pathophysiology, and Emerging Immunotherapies. Curr Issu Molec Biol. 2023;45(11):8816\u20138839. doi:10.3390/cimb45110553", "ArticleIdList": ["10.3390/cimb45110553", "PMC10670294", "37998730"]}, {"Citation": "Michalicova A, Majerova P, Kovac A. Tau protein and its role in blood\u2013brain barrier dysfunction. Front Molec Neurosci. 2020;13:570045. doi:10.3389/fnmol.2020.570045", "ArticleIdList": ["10.3389/fnmol.2020.570045", "PMC7554615", "33100967"]}, {"Citation": "Guha S, Johnson GV, Nehrke K. The crosstalk between pathological tau phosphorylation and mitochondrial dysfunction as a key to understanding and treating Alzheimer\u2019s disease. Mol Neurobiol. 2020;57:5103\u20135120. doi:10.1007/s12035-020-02084-0", "ArticleIdList": ["10.1007/s12035-020-02084-0", "PMC7544674", "32851560"]}, {"Citation": "Wang L, Yin Y-L, Liu X-Z, et al. Current understanding of metal ions in the pathogenesis of Alzheimer\u2019s disease. Translat Neurodeg. 2020;9(1):1\u201313. doi:10.1186/s40035-020-00189-z", "ArticleIdList": ["10.1186/s40035-020-00189-z", "PMC7119290", "32266063"]}, {"Citation": "Maitra S, Vincent B. Cdk5-p25 as a key element linking amyloid and tau pathologies in Alzheimer\u2019s disease: mechanisms and possible therapeutic interventions. Life Sci. 2022;308:120986. doi:10.1016/j.lfs.2022.120986", "ArticleIdList": ["10.1016/j.lfs.2022.120986", "36152679"]}, {"Citation": "Jiang H, Wang X, Zhang H, Chang Y, Feng M, Wu S. Loss\u2010of\u2010function mutation of serine racemase attenuates excitotoxicity by intravitreal injection of N\u2010methyl\u2010D\u2010aspartate. J Neuroch. 2016;136(1):186\u2013193. doi:10.1111/jnc.13400", "ArticleIdList": ["10.1111/jnc.13400", "26485193"]}, {"Citation": "Pannaccione A, Piccialli I, Secondo A, et al. The Na+/Ca2+ exchanger in Alzheimer\u2019s disease. Cell Calcium. 2020;87:102190. doi:10.1016/j.ceca.2020.102190", "ArticleIdList": ["10.1016/j.ceca.2020.102190", "32199208"]}, {"Citation": "Kumar A, Behl T, Jamwal S, Kaur I, Sood A, Kumar P. Exploring the molecular approach of COX and LOX in Alzheimer\u2019s and Parkinson\u2019s disorder. Molec Biol Rep. 2020;47:9895\u20139912. doi:10.1007/s11033-020-06033-x", "ArticleIdList": ["10.1007/s11033-020-06033-x", "33263931"]}, {"Citation": "Allan Butterfield D. Amyloid \u03b2-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer\u2019s disease brain. A review. Free Rad Res. 2002;36(12):1307\u20131313. doi:10.1080/1071576021000049890", "ArticleIdList": ["10.1080/1071576021000049890", "12607822"]}, {"Citation": "Rai SN, Singh C, Singh A, Singh M, Singh BK. Mitochondrial dysfunction: a potential therapeutic target to treat Alzheimer\u2019s disease. Mol Neurobiol. 2020;57:3075\u20133088. doi:10.1007/s12035-020-01945-y", "ArticleIdList": ["10.1007/s12035-020-01945-y", "32462551"]}, {"Citation": "Wen L-Y, Wan L, Lai J-N, et al. Increased risk of Alzheimer\u2019s disease among patients with age-related macular degeneration: a nationwide population-based study. PLoS One. 2021;16(5):e0250440. doi:10.1371/journal.pone.0250440", "ArticleIdList": ["10.1371/journal.pone.0250440", "PMC8104445", "33961642"]}, {"Citation": "Butterfield DA, Kanski J. Brain protein oxidation in age-related neurodegenerative disorders that are associated with aggregated proteins. Mechan Age Develop. 2001;122(9):945\u2013962. doi:10.1016/S0047-6374(01)00249-4", "ArticleIdList": ["10.1016/S0047-6374(01)00249-4", "11348660"]}, {"Citation": "Lin MT, Beal MF. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 2006;443(7113):787\u2013795. doi:10.1038/nature05292", "ArticleIdList": ["10.1038/nature05292", "17051205"]}, {"Citation": "Lyras L, Cairns NJ, Jenner A, Jenner P, Halliwell B. An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer\u2019s disease. J Neurochem. 1997;68(5):2061\u20132069. doi:10.1046/j.1471-4159.1997.68052061.x", "ArticleIdList": ["10.1046/j.1471-4159.1997.68052061.x", "9109533"]}, {"Citation": "Ercal N, Gurer-Orhan H, Aykin-Burns N. Toxic metals and oxidative stress part I: mechanisms involved in metal-induced oxidative damage. Curr Top Med Chem. 2001;1(6):529\u2013539. doi:10.2174/1568026013394831", "ArticleIdList": ["10.2174/1568026013394831", "11895129"]}, {"Citation": "Teleanu DM, Niculescu A-G, Lungu II, et al. An overview of oxidative stress, neuroinflammation, and neurodegenerative diseases. Internat J Molecul Sci. 2022;23(11):5938. doi:10.3390/ijms23115938", "ArticleIdList": ["10.3390/ijms23115938", "PMC9180653", "35682615"]}, {"Citation": "Zafar S. Chief Role of Neuroinflammation and Oxidative Stress in Brain Disorders. In: The Role of Natural Antioxidants in Brain Disorders. Springer; 2023:89\u2013109."}, {"Citation": "Chen X, Holtzman DM. Emerging roles of innate and adaptive immunity in Alzheimer\u2019s disease. Immunity. 2022;55:2236\u20132254. doi:10.1016/j.immuni.2022.10.016", "ArticleIdList": ["10.1016/j.immuni.2022.10.016", "PMC9772134", "36351425"]}, {"Citation": "Jabeen K, Rehman K, Akash MSH. Genetic mutations of APOE\u03b54 carriers in cardiovascular patients lead to the development of insulin resistance and risk of Alzheimer\u2019s disease. J Biochem Mol Toxicol. 2022;36(2):e22953. doi:10.1002/jbt.22953", "ArticleIdList": ["10.1002/jbt.22953", "34757642"]}, {"Citation": "Yamazaki Y, Zhao N, Caulfield TR, Liu -C-C, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501\u2013518. doi:10.1038/s41582-019-0228-7", "ArticleIdList": ["10.1038/s41582-019-0228-7", "PMC7055192", "31367008"]}, {"Citation": "Cai Z, Zhao Y, Zhao B. Roles of glycogen synthase kinase 3 in Alzheimer\u2019s disease. Curr Alzh Res. 2012;9(7):864\u2013879. doi:10.2174/156720512802455386", "ArticleIdList": ["10.2174/156720512802455386", "22272620"]}, {"Citation": "Kumari S, Singh A, Singh AK, et al. Circulatory GSK-3\u03b2: blood-based biomarker and therapeutic target for Alzheimer\u2019s disease. J Alzheim Dis. 2022;85(1):249\u2013260. doi:10.3233/JAD-215347", "ArticleIdList": ["10.3233/JAD-215347", "34776454"]}, {"Citation": "Yang Y, Wang L, Zhang C, et al. Ginsenoside Rg1 improves Alzheimer\u2019s disease by regulating oxidative stress, apoptosis, and neuroinflammation through Wnt/GSK\u20103\u03b2/\u03b2\u2010catenin signaling pathway. Chem Biol Drug Des. 2022;99(6):884\u2013896. doi:10.1111/cbdd.14041", "ArticleIdList": ["10.1111/cbdd.14041", "35313087"]}, {"Citation": "Sun Y, Ai JZ, Jin X, et al. IL\u20108 protects prostate cancer cells from GSK\u20103\u03b2\u2010induced oxidative stress by activating the mTOR signaling pathway. Prostate. 2019;79(10):1180\u20131190. doi:10.1002/pros.23836", "ArticleIdList": ["10.1002/pros.23836", "31104320"]}, {"Citation": "Barber K, Mendonca P, Soliman KF. The neuroprotective effects and therapeutic potential of the chalcone cardamonin for Alzheimer\u2019s disease. Brain Sci. 2023;13(1):145. doi:10.3390/brainsci13010145", "ArticleIdList": ["10.3390/brainsci13010145", "PMC9856590", "36672126"]}, {"Citation": "Parhizkar S, Holtzman DM. APOE mediated neuroinflammation and neurodegeneration in Alzheimer\u2019s disease. Paper presented at: Seminars in immunology; 2022.", "ArticleIdList": ["PMC9411266", "35232622"]}, {"Citation": "Xu L, He D, Bai Y. Microglia-mediated inflammation and neurodegenerative disease. Molecul Neurobiol. 2016;53(10):6709\u20136715. doi:10.1007/s12035-015-9593-4", "ArticleIdList": ["10.1007/s12035-015-9593-4", "26659872"]}, {"Citation": "Wyss-Coray T, Mucke L. Inflammation in neurodegenerative disease\u2014a double-edged sword. Neuron. 2002;35(3):419\u2013432. doi:10.1016/S0896-6273(02)00794-8", "ArticleIdList": ["10.1016/S0896-6273(02)00794-8", "12165466"]}, {"Citation": "Asthana A, Tripathi S, Agarwal R. A systematic review and meta-analysis of randomized control trials to check role of non-steroidal anti-inflammatory drugs as protective factor in Alzheimer disease subjects. Advan Alzheim Dis. 2023;12(1):1\u201316. doi:10.4236/aad.2023.121001", "ArticleIdList": ["10.4236/aad.2023.121001"]}, {"Citation": "Jiao X, Ashtari N, Rahimi-Balaei M, et al. Mevalonate cascade and neurodevelopmental and neurodegenerative diseases: future targets for therapeutic application. Curr Mol Pharmacol. 2017;10(2):115\u2013140. doi:10.2174/1874467209666160112125446", "ArticleIdList": ["10.2174/1874467209666160112125446", "26758948"]}, {"Citation": "Shrivastava S Kumar, Patel B K, Tripathi P Nath, Srivastava P, Sharma P, Tripathi A, Seth A and Tripathi M Kumar. (2018). Synthesis, evaluation and docking studies of some 4-thiazolone derivatives as effective lipoxygenase inhibitors. Chem. Pap., 72(11), 2769\u20132783. doi:10.1007/s11696-018-0520-9", "ArticleIdList": ["10.1007/s11696-018-0520-9"]}, {"Citation": "Peauger L, Azzouz R, Gembus V, et al. Donepezil-based central acetylcholinesterase inhibitors by means of a \u201cbio-oxidizable\u201d prodrug strategy: design, synthesis, and in vitro biological evaluation. J Med Chem. 2017;60(13):5909\u20135926. doi:10.1021/acs.jmedchem.7b00702", "ArticleIdList": ["10.1021/acs.jmedchem.7b00702", "28613859"]}, {"Citation": "Grutzendler J, Morris JC. Cholinesterase inhibitors for Alzheimer\u2019s disease. Drugs. 2001;61:41\u201352. doi:10.2165/00003495-200161010-00005", "ArticleIdList": ["10.2165/00003495-200161010-00005", "11217870"]}, {"Citation": "Hansen RA, Gartlehner G, Webb AP, Morgan LC, Moore CG, Jonas DE. Efficacy and safety of donepezil, galantamine, and rivastigmine for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis. Clin Intervent Aging. 2008;3(2):211\u2013225.", "ArticleIdList": ["PMC2546466", "18686744"]}, {"Citation": "Li Q, He S, Chen Y, Feng F, Qu W, Sun H. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer\u2019s disease. Europ J Med Chem. 2018;158:463\u2013477. doi:10.1016/j.ejmech.2018.09.031", "ArticleIdList": ["10.1016/j.ejmech.2018.09.031", "30243151"]}, {"Citation": "Gottwald MD, Rozanski RI. Rivastigmine, a brain-region selective acetylcholinesterase inhibitor for treating Alzheimer\u2019s disease: review and current status. Expert Opin Investigational Drugs. 1999;8(10):1673\u20131682. doi:10.1517/13543784.8.10.1673", "ArticleIdList": ["10.1517/13543784.8.10.1673", "11139819"]}, {"Citation": "Hopkins TJ, Rupprecht LE, Hayes MR, Blendy JA, Schmidt HD. Galantamine, an acetylcholinesterase inhibitor and positive allosteric modulator of nicotinic acetylcholine receptors, attenuates nicotine taking and seeking in rats. Neuropsychopharmacol. 2012;37(10):2310\u20132321. doi:10.1038/npp.2012.83", "ArticleIdList": ["10.1038/npp.2012.83", "PMC3422495", "22669169"]}, {"Citation": "Lilienfeld S. Galantamine\u2014a novel cholinergic drug with a unique dual mode of action for the treatment of patients with Alzheimer\u2019s disease. CNS Drug Rev. 2002;8(2):159\u2013176. doi:10.1111/j.1527-3458.2002.tb00221.x", "ArticleIdList": ["10.1111/j.1527-3458.2002.tb00221.x", "PMC6741688", "12177686"]}, {"Citation": "Gohil K. Investigation of banglenes as neurotrophic agents and development of a new fluorescent protein-based FRET pair; 2022."}, {"Citation": "Amalraj A, Ac KV, Jude S, Kuttappan S. Galangal\u2014Roles in nutraceuticals and functional foods. In: Herbs, Spices and Their Roles in Nutraceuticals and Functional Foods. Elsevier; 2023:95\u2013109."}, {"Citation": "Husain A, Al Balushi K, Akhtar MJ, Khan SA. Coumarin linked heterocyclic hybrids: a promising approach to develop multi target drugs for Alzheimer\u2019s disease. J Molec Struct. 2021;1241:130618. doi:10.1016/j.molstruc.2021.130618", "ArticleIdList": ["10.1016/j.molstruc.2021.130618"]}, {"Citation": "Jantrachotechatchawan C. Contribution of Cholinergic Innervation to Adult Hippocampal Neurogenesis in Dementia. King\u2019s College London; 2019."}, {"Citation": "Atlante A, Amadoro G, Latina V, Valenti D. Therapeutic potential of targeting mitochondria for Alzheimer\u2019s disease treatment. J Clin Med. 2022;11(22):6742. doi:10.3390/jcm11226742", "ArticleIdList": ["10.3390/jcm11226742", "PMC9697019", "36431219"]}, {"Citation": "Seval N, Eaton E, Springer SA. Inpatient opioid use disorder treatment for the infectious disease physician. In: The Opioid Epidemic and Infectious Diseases. Elsevier; 2021:189\u2013221."}, {"Citation": "Tari PK, Parsons CG, Collingridge GL, Rammes G. Memantine: updating a rare success story in pro-cognitive therapeutics. Neuropharmacology. 2023;109737. doi:10.1016/j.neuropharm.2023.109737", "ArticleIdList": ["10.1016/j.neuropharm.2023.109737", "37832633"]}, {"Citation": "Jiang N. Plasticity of Hippocampal Synaptic Transmission and Intrinsic Excitability in a Mouse Model of Alzheimer\u2019s Disease. Universit\u00e9 de Bordeaux; 2019."}, {"Citation": "Kikuchi T. Is memantine effective as an NMDA receptor antagonist in adjunctive therapy for schizophrenia? Biomolecules. 2020;10(8):1134. doi:10.3390/biom10081134", "ArticleIdList": ["10.3390/biom10081134", "PMC7466074", "32751985"]}, {"Citation": "Kolcheva M. Functional and pharmacological properties of GluN1/GluN2 and GluN1/GluN3 subtypes of NMDA receptors; 2023."}, {"Citation": "Zhou Y-Q, Yang Z-L, Xu L, Li P, Y-Z H. Akebia saponin D, a saponin component from Dipsacus asper Wall, protects PC 12 cells against amyloid-\u03b2 induced cytotoxicity. Cell Biol Internat. 2009;33(10):1102\u20131110. doi:10.1016/j.cellbi.2009.06.028", "ArticleIdList": ["10.1016/j.cellbi.2009.06.028", "19615455"]}, {"Citation": "Mehta M, Adem A, Sabbagh M. New acetylcholinesterase inhibitors for Alzheimer\u2019s disease. Internat J Alzh Dis. 2012;2012. doi:10.1155/2012/728983", "ArticleIdList": ["10.1155/2012/728983", "PMC3246720", "22216416"]}, {"Citation": "Mullard A. Sting of Alzheimer\u2019s failures offset by upcoming prevention trials: three prevention trials in asymptomatic Alzheimer\u2019s disease patients will attempt to validate the amyloid hypothesis, evaluate biomarkers and set the stage for drug approvals. Nat Rev Drug Disc. 2012;11(9):657\u2013661. doi:10.1038/nrd3842", "ArticleIdList": ["10.1038/nrd3842", "22935790"]}, {"Citation": "Ashford JW, Mahoney L, Burkett T. A role for complementary and integrative medicine in Alzheimer\u2019s disease prevention. J Alzh Dis. 2015;48(1):13\u201314. doi:10.3233/JAD-150505", "ArticleIdList": ["10.3233/JAD-150505", "26401924"]}, {"Citation": "Huegel HM. Brain food for Alzheimer-free ageing: focus on herbal medicines. Nat Comp Therap Age Amyloidog Dis. 2015;2015:95\u2013116.", "ArticleIdList": ["26092628"]}, {"Citation": "Li N, Zhou L, Li W, Liu Y, Wang J, He P. Protective effects of ginsenosides Rg1 and Rb1 on an Alzheimer\u2019s disease mouse model: a metabolomics study. J Chromat. 2015;985:54\u201361. doi:10.1016/j.jchromb.2015.01.016", "ArticleIdList": ["10.1016/j.jchromb.2015.01.016", "25660715"]}, {"Citation": "Yan S, Li Z, Li H, Arancio O, Zhang W. Notoginsenoside R1 increases neuronal excitability and ameliorates synaptic and memory dysfunction following amyloid elevation. Scien Rep. 2014;4(1):6352. doi:10.1038/srep06352", "ArticleIdList": ["10.1038/srep06352", "PMC4161968", "25213453"]}, {"Citation": "Malve H. Management of Alzheimer\u2019s disease: role of existing therapies, traditional medicines and new treatment targets. Indian J Pharmac Sci. 2017;79(1). doi:10.4172/pharmaceutical-sciences.1000195", "ArticleIdList": ["10.4172/pharmaceutical-sciences.1000195"]}, {"Citation": "Patwardhan B, Datta HS. Ayurveda and Brain health. In: Nutraceuticals in Brain Health and Beyond. Elsevier; 2021:441\u2013453."}, {"Citation": "Shown S. Efficacy of Kushmanda (Benincasa Hispida) Swarasa in Mild Cognitive Impairment (MCI) of the Elderly. India: Rajiv Gandhi University of Health Sciences; 2018."}, {"Citation": "Nesari TM, Sanwal CS, Rath C, et al. Traditional Medicine Review; 2023."}, {"Citation": "Barve M, Mashru M, Jagtap C, Patgiri B, Prajapati P, Prajapati PK. Therapeutic potentials of metals in ancient India: a review through Charaka Samhita. J Ayurv Integrat Med. 2011;2(2):55. doi:10.4103/0975-9476.82523", "ArticleIdList": ["10.4103/0975-9476.82523", "PMC3131772", "21760689"]}, {"Citation": "Madhavi A, Savitha H. Depression-an Ayurvedic outlook. J Ayu Holistic Med. 2017;5(2):12\u201323."}, {"Citation": "Prajapati KK, Pande P, Acharya P. Ayurveda view on daivavyapashraya chikitsa: A; 2022."}, {"Citation": "Sharma R, Amin H. Rasayana Therapy: ayurvedic contribution to improve quality of life. World J Pharmacol Res Tech. 2015;4:23\u201333."}, {"Citation": "Saraf P, Tripathi PN, Tripathi MK, et al. Novel 5, 6-diphenyl-1, 2, 4-triazine-3-thiol derivatives as dual COX-2/5-LOX inhibitors devoid of cardiotoxicity. Bioorg Chem. 2022;129:106147. doi:10.1016/j.bioorg.2022.106147", "ArticleIdList": ["10.1016/j.bioorg.2022.106147", "36126607"]}, {"Citation": "Dastmalchi K, Dorman HD, Vuorela H, Hiltunen R. Plants as potential sources for drug development against Alzheimer\u2019s disease. Int J Biomed Pharm Sci. 2007;1(2):83\u2013104."}, {"Citation": "Simunkova M, Alwasel SH, Alhazza IM, et al. Management of oxidative stress and other pathologies in Alzheimer\u2019s disease. Arch Toxicol. 2019;93:2491\u20132513. doi:10.1007/s00204-019-02538-y", "ArticleIdList": ["10.1007/s00204-019-02538-y", "31440798"]}, {"Citation": "Yoo K-Y, Park S-Y. Terpenoids as potential anti-Alzheimer\u2019s disease therapeutics. Molecules. 2012;17(3):3524\u20133538. doi:10.3390/molecules17033524", "ArticleIdList": ["10.3390/molecules17033524", "PMC6268347", "22430119"]}, {"Citation": "Singh AK, Rai SN, Maurya A, et al. Therapeutic potential of phytoconstituents in management of Alzheimer\u2019s disease. Evid Bas Complement Alternat Med. 2021;2021:1\u201319. doi:10.1155/2021/5578574", "ArticleIdList": ["10.1155/2021/5578574", "PMC8208882", "34211570"]}, {"Citation": "Ahmed F, Chandra J, Urooj A, Rangappa K. In vitro antioxidant and anticholinesterase activity of Acorus calamus and Nardostachys jatamansi rhizomes. J Phar Res. 2009;2(5):830\u2013883."}, {"Citation": "Vohora S, Shah SA, Dandiya P. Central nervous system studies on an ethanol extract of Acorus calamus rhizomes. J Ethnopharmacol. 1990;28(1):53\u201362. doi:10.1016/0378-8741(90)90065-2", "ArticleIdList": ["10.1016/0378-8741(90)90065-2", "2314110"]}, {"Citation": "Sharma V, Sharma R, Gautam DS, Kuca K, Nepovimova E, Martins N. Role of Vacha (Acorus calamus Linn.) in neurological and metabolic disorders: evidence from ethnopharmacology, phytochemistry, pharmacology and clinical study. J Clin Med. 2020;9(4):1176. doi:10.3390/jcm9041176", "ArticleIdList": ["10.3390/jcm9041176", "PMC7230970", "32325895"]}, {"Citation": "Mukherjee PK, Kumar V, Mal M, Houghton PJ. Acetylcholinesterase inhibitors from plants. Phytomedicine. 2007;14(4):289\u2013300. doi:10.1016/j.phymed.2007.02.002", "ArticleIdList": ["10.1016/j.phymed.2007.02.002", "17346955"]}, {"Citation": "Li D, Ma J, Wei B, Gao S, Lang Y, Wan X. Effectiveness and safety of ginkgo biloba preparations in the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis. Front Aging Neurosci. 2023;15:1124710. doi:10.3389/fnagi.2023.1124710", "ArticleIdList": ["10.3389/fnagi.2023.1124710", "PMC10028084", "36960422"]}, {"Citation": "Assump\u00e7\u00e3o CF, Bachiega P, Morzelle MC, et al. Characterization, antioxidant potential and cytotoxic study of mangaba fruits. Ci\u00eancia Rural. 2014;44:1297\u20131303. doi:10.1590/0103-8478cr20130855", "ArticleIdList": ["10.1590/0103-8478cr20130855"]}, {"Citation": "Choi BW, Lee HS, Shin HC, Lee BH. Multifunctional activity of polyphenolic compounds associated with a potential for Alzheimer\u2019s disease therapy from Ecklonia cava. Phytoth Res. 2015;29(4):549\u2013553. doi:10.1002/ptr.5282", "ArticleIdList": ["10.1002/ptr.5282", "25640212"]}, {"Citation": "El-Hawary SS, Fathy FI, Sleem AA, Morsy FA, Khadar MS, Mansour MK. Anticholinesterase activity and metabolite profiling of Syagrus romanzoffiana (Cham.) Glassman leaves and fruits via UPLC\u2013QTOF\u2013PDA\u2013MS. Nat Prod Res. 2021;35(10):1671\u20131675. doi:10.1080/14786419.2019.1622113", "ArticleIdList": ["10.1080/14786419.2019.1622113", "31148478"]}, {"Citation": "Imran M, Ullah F, Ayaz M, et al. Anticholinesterase and antioxidant potentials of Nonea micrantha Bioss. & Reut along with GC-MS analysis. BMC Complement Alternat Med. 2017;17(1):1\u201312. doi:10.1186/s12906-017-2004-9", "ArticleIdList": ["10.1186/s12906-017-2004-9", "PMC5701353", "29169349"]}, {"Citation": "Kaur N, Sarkar B, Gill I, et al. Indian herbs and their therapeutic potential against Alzheimer\u2019s disease and other neurological disorders. Neuroprot Effe Phytochem Neurolog Dis. 2017;2017:79\u2013112."}, {"Citation": "Panossian A, Seo E-J, Efferth T. Effects of anti-inflammatory and adaptogenic herbal extracts on gene expression of eicosanoids signaling pathways in isolated brain cells. Phytomedicine. 2019;60:152881. doi:10.1016/j.phymed.2019.152881", "ArticleIdList": ["10.1016/j.phymed.2019.152881", "30987861"]}, {"Citation": "Khojah H, Edrada-Ebel R. P43 the isolation and purification of bioactive metabolites from Ficus carica and their neuroprotective effects in Alzheimer\u2019s disease. Biochem Pharmacol. 2017;139:140. doi:10.1016/j.bcp.2017.06.044", "ArticleIdList": ["10.1016/j.bcp.2017.06.044"]}, {"Citation": "Chen H-Y, Yen G-C. Antioxidant activity and free radical-scavenging capacity of extracts from guava (Psidium guajava L.) leaves. Food Chem. 2007;101(2):686\u2013694. doi:10.1016/j.foodchem.2006.02.047", "ArticleIdList": ["10.1016/j.foodchem.2006.02.047"]}, {"Citation": "Aly SH, Eldahshan OA, Al-Rashood ST, et al. Chemical constituents, antioxidant, and enzyme inhibitory activities supported by in-silico study of n-hexane extract and essential oil of guava leaves. Molecules. 2022;27(24):8979. doi:10.3390/molecules27248979", "ArticleIdList": ["10.3390/molecules27248979", "PMC9781903", "36558111"]}, {"Citation": "Kamran M, Kousar R, Ullah S, et al. Taxonomic distribution of medicinal plants for Alzheimer\u2019s Disease: a cue to novel drugs. Internat J Alzh Dis. 2020;2020:1\u201315. doi:10.1155/2020/7603015", "ArticleIdList": ["10.1155/2020/7603015"]}, {"Citation": "Choi BW, Ryu G, Park SH, et al. Anticholinesterase activity of plastoquinones from Sargassum sagamianum: lead compounds for Alzheimer\u2019s disease therapy. Phytoth Res. 2007;21(5):423\u2013426. doi:10.1002/ptr.2090", "ArticleIdList": ["10.1002/ptr.2090", "17236179"]}, {"Citation": "Bhattacharjee S, Banerjee N, Chatterjee S, et al. Role of turmeric in management of different non-communicable diseases. World J Pharm Pharmac Sci. 2017;6(7):1767\u20131778."}, {"Citation": "Uddin MJ, Alam MN, Biswas K, Rahman MA. In vitro antioxidative and cholinesterase inhibitory properties of Thunbergia grandiflora leaf extract. Cogent Food Agricult. 2016;2(1):1256929. doi:10.1080/23311932.2016.1256929", "ArticleIdList": ["10.1080/23311932.2016.1256929"]}, {"Citation": "Penido AB, De Morais SM, Ribeiro AB, et al. Medicinal plants from northeastern Brazil against Alzheimer\u2019s disease. Evid Bas Complement Altern Med. 2017;2017. doi:10.1155/2017/1753673", "ArticleIdList": ["10.1155/2017/1753673", "PMC5339485", "28316633"]}, {"Citation": "Panche AN, Chandra S, Diwan A. Multi-target \u03b2-protease inhibitors from Andrographis paniculata: in silico and in vitro studies. Plants. 2019;8(7):231. doi:10.3390/plants8070231", "ArticleIdList": ["10.3390/plants8070231", "PMC6681301", "31319560"]}, {"Citation": "Sobhani R, Pal AK, Bhattacharjee A, Mitra S, Aguan K. Screening indigenous medicinal plants of Northeast India for their anti-Alzheimer\u2019s properties. Pharmacog J. 2017;9(1):1."}, {"Citation": "Cioanca O, Hritcu L, Mihasan M, Trifan A, Hancianu M. Inhalation of coriander volatile oil increased anxiolytic\u2013antidepressant-like behaviors and decreased oxidative status in beta-amyloid (1\u201342) rat model of Alzheimer\u2019s disease. Physiol Behav. 2014;131:68\u201374. doi:10.1016/j.physbeh.2014.04.021", "ArticleIdList": ["10.1016/j.physbeh.2014.04.021", "24747275"]}, {"Citation": "Zarmouh NO, Messeha SS, Elshami FM, Soliman KF. Natural products screening for the identification of selective monoamine oxidase-B inhibitors. Europ J Med Plant. 2016;15(1):1\u201316. doi:10.9734/EJMP/2016/26453", "ArticleIdList": ["10.9734/EJMP/2016/26453", "PMC4898948", "27341283"]}, {"Citation": "Sabzehzari M, Naghavi MR, Bozari M, Orafai HM, Johnston TP, Sahebkar A. Pharmacological and therapeutic aspects of plants from the genus Ferula: a comprehensive review. Mini Rev Med Chem. 2020;20(13):1233\u20131257. doi:10.2174/1389557520666200505125618", "ArticleIdList": ["10.2174/1389557520666200505125618", "32368975"]}, {"Citation": "Sithisarn P, Jarikasem S. Antioxidant activity of Acanthopanax trifoliatus. Med Princip Pract. 2009;18(5):393\u2013398. doi:10.1159/000226294", "ArticleIdList": ["10.1159/000226294", "19648763"]}, {"Citation": "Feroz F, Naeem I, Nawaz SA, Khan N, Khan MR, Choudhary MI. New pregnane-type steroidal alkaloids from Sarcococca saligna and their cholinesterase inhibitory activity. Steroids. 2004;69(11\u201312):735\u2013741. doi:10.1016/j.steroids.2004.03.016", "ArticleIdList": ["10.1016/j.steroids.2004.03.016", "15685740"]}, {"Citation": "Parveen S, Farooq A, Farooq A, Choudhary MI, Choudhary MI. Acetyl and butyrylcholinesterase-inhibiting triterpenoid alkaloids from Buxus papillosa. Phytochemistry. 2001;58(6):963\u2013968. doi:10.1016/S0031-9422(01)00332-6", "ArticleIdList": ["10.1016/S0031-9422(01)00332-6", "11684196"]}, {"Citation": "Hostettmann K, Borloz A, Urbain A, Marston A. Natural product inhibitors of acetylcholinesterase. Curr Org Chem. 2006;10(8):825\u2013847. doi:10.2174/138527206776894410", "ArticleIdList": ["10.2174/138527206776894410"]}, {"Citation": "Chen Y, Zhang J, Zhang B, Gong C-X. Targeting insulin signaling for the treatment of Alzheimer\u2019s disease. Curr Top Med Chem. 2016;16(5):485\u2013492. doi:10.2174/1568026615666150813142423", "ArticleIdList": ["10.2174/1568026615666150813142423", "26268336"]}, {"Citation": "Batista \u00c2G, Ferrari AS, da Cunha DC, et al. Polyphenols, antioxidants, and antimutagenic effects of Copaifera langsdorffii fruit. Food Chemistry. 2016;197:1153\u20131159. doi:10.1016/j.foodchem.2015.11.093", "ArticleIdList": ["10.1016/j.foodchem.2015.11.093", "26675852"]}, {"Citation": "Kaur N, Sarkar B, Gill I, et al. Indian herbs and their therapeutic potential against Alzheimer\u2019s disease: what makes them special? Neuroprot Eff Phytochem Neurolog Dis. 2016;2016:1."}, {"Citation": "Damodaran T, Tan BWL, Liao P, Ramanathan S, Lim GK, Hassan Z. Clitoria ternatea L. root extract ameliorated the cognitive and hippocampal long-term potentiation deficits induced by chronic cerebral hypoperfusion in the rat. J Ethnopharmacol. 2018;224:381\u2013390. doi:10.1016/j.jep.2018.06.020", "ArticleIdList": ["10.1016/j.jep.2018.06.020", "29920356"]}, {"Citation": "Vladimir-Kne\u017eevi\u0107 S, Bla\u017eekovi\u0107 B, Kindl M, Vladi\u0107 J, Lower-Nedza AD, Brantner AH. Acetylcholinesterase inhibitory, antioxidant and phytochemical properties of selected medicinal plants of the Lamiaceae family. Molecules. 2014;19(1):767\u2013782. doi:10.3390/molecules19010767", "ArticleIdList": ["10.3390/molecules19010767", "PMC6271370", "24413832"]}, {"Citation": "Oskouie AA, Yekta RF, Tavirani MR, Kashani MS, Goshadrou F. Lavandula angustifolia effects on rat models of Alzheimer\u2019s disease through the investigation of serum metabolic features using NMR metabolomics. Avic J Med Biotech. 2018;10(2):83.", "ArticleIdList": ["PMC5960064", "29849984"]}, {"Citation": "Soheili M, Tavirani MR, Salami M. Lavandula angustifolia extract improves deteriorated synaptic plasticity in an animal model of Alzheimer\u2019s disease. Iranian J Bas Med Sci. 2015;18(11):1147.", "ArticleIdList": ["PMC4764119", "26949505"]}, {"Citation": "Rychlik M. Quantification of free coumarin and its liberation from glucosylated precursors by stable isotope dilution assays based on liquid chromatography\u2212 tandem mass spectrometric detection. J Agricult Food Chem. 2008;56(3):796\u2013801. doi:10.1021/jf0728348", "ArticleIdList": ["10.1021/jf0728348", "18197622"]}, {"Citation": "Rafii M, Walsh S, Little J, et al. A Phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology. 2011;76(16):1389\u20131394. doi:10.1212/WNL.0b013e318216eb7b", "ArticleIdList": ["10.1212/WNL.0b013e318216eb7b", "PMC3269774", "21502597"]}, {"Citation": "Calder\u00f3n AI, Simithy-Williams J, Sanchez R, Espinosa A, Valdespino I, Gupta MP. Lycopodiaceae from Panama: a new source of acetylcholinesterase inhibitors. Natural Prod Res. 2013;27(4\u20135):500\u2013505. doi:10.1080/14786419.2012.701217", "ArticleIdList": ["10.1080/14786419.2012.701217", "22746970"]}, {"Citation": "Howes M-JR, Fang R, Houghton PJ. Effect of Chinese herbal medicine on Alzheimer\u2019s disease. Internat Rev Neurobiol. 2017;135:29\u201356.", "ArticleIdList": ["28807163"]}, {"Citation": "Dwivedi C, Chandrakar K, Singh V, et al. Indian herbal medicines used for treatment of dementia: an overview. Internat J Pharmacog. 2014;1(9):353\u2013371."}, {"Citation": "Limpeanchob N, Jaipan S, Rattanakaruna S, Phrompittayarat W, Ingkaninan K. Neuroprotective effect of Bacopa monnieri on beta-amyloid-induced cell death in primary cortical culture. J Ethnopharmacol. 2008;120(1):112\u2013117. doi:10.1016/j.jep.2008.07.039", "ArticleIdList": ["10.1016/j.jep.2008.07.039", "18755259"]}, {"Citation": "Sehgal N, Gupta A, Valli RK, et al. Withania somnifera reverses Alzheimer\u2019s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proceed Nat Acad Sci. 2012;109(9):3510\u20133515. doi:10.1073/pnas.1112209109", "ArticleIdList": ["10.1073/pnas.1112209109", "PMC3295277", "22308347"]}, {"Citation": "Kim B-W, Koppula S, Park S-Y, et al. Attenuation of inflammatory-mediated neurotoxicity by Saururus chinensis extract in LPS-induced BV-2 microglia cells via regulation of NF-\u03baB signaling and anti-oxidant properties. BMC Complement Altern Med. 2014;14:1\u201310. doi:10.1186/1472-6882-14-502", "ArticleIdList": ["10.1186/1472-6882-14-502", "PMC4301828", "25514974"]}, {"Citation": "Sung SH, Kwon SH, Cho NJ, Kim YC. Hepatoprotective flavonol glycosides of Saururus chinensis herbs. Phytoth Res. 1997;11(7):500\u2013503. doi:10.1002/(SICI)1099-1573(199711)11:7<500::AID-PTR139>3.0.CO;2-P", "ArticleIdList": ["10.1002/(SICI)1099-1573(199711)11:7<500::AID-PTR139>3.0.CO;2-P"]}, {"Citation": "Wang B. Chemical characterization and ameliorating effect of polysaccharide from Chinese jujube on intestine oxidative injury by ischemia and reperfusion. Internat J Biolog Macromolec. 2011;48(3):386\u2013391. doi:10.1016/j.ijbiomac.2010.12.005", "ArticleIdList": ["10.1016/j.ijbiomac.2010.12.005", "21145346"]}, {"Citation": "Hosseini M, Mohammadpour T, Karami R, Rajaei Z, Reza Sadeghnia H, Soukhtanloo M. Effects of the hydro-alcoholic extract of Nigella sativa on scopolamine-induced spatial memory impairment in rats and its possible mechanism. Chin J Integ Med. 2015;21:438\u2013444. doi:10.1007/s11655-014-1742-5", "ArticleIdList": ["10.1007/s11655-014-1742-5", "24584756"]}, {"Citation": "Khazdair MR. The protective effects of Nigella sativa and its constituents on induced neurotoxicity. J Toxicol. 2015;2015. doi:10.1155/2015/841823", "ArticleIdList": ["10.1155/2015/841823", "PMC4641935", "26604923"]}, {"Citation": "Cascella M, Bimonte S, Barbieri A, et al. Dissecting the potential roles of nigella sativa and its constituent thymoquinone on the prevention and on the progression of Alzheimer\u2019s disease. Front Aging Neurosci. 2018;10:16. doi:10.3389/fnagi.2018.00016", "ArticleIdList": ["10.3389/fnagi.2018.00016", "PMC5811465", "29479315"]}, {"Citation": "Choudhary S, Kumar P, Malik J. Plants and phytochemicals for Huntington\u2019s disease. Pharmacog Rev. 2013;7(14):81. doi:10.4103/0973-7847.120505", "ArticleIdList": ["10.4103/0973-7847.120505", "PMC3841999", "24347915"]}, {"Citation": "Mir NT, Saleem U, Anwar F, et al. Lawsonia Inermis markedly improves cognitive functions in animal models and modulate oxidative stress markers in the brain. Medicina. 2019;55(5):192. doi:10.3390/medicina55050192", "ArticleIdList": ["10.3390/medicina55050192", "PMC6571555", "31121979"]}, {"Citation": "Wang Y-H, Du G-H. Ginsenoside Rg1 inhibits \u03b2-secretase activity in vitro and protects against A\u03b2-induced cytotoxicity in PC12 cells. J Asian Nat Prod Res. 2009;11(7):604\u2013612. doi:10.1080/10286020902843152", "ArticleIdList": ["10.1080/10286020902843152", "20183297"]}, {"Citation": "Qu J, Xu N, Zhang J, Geng X, Zhang R. Panax notoginseng saponins and their applications in nervous system disorders: a narrative review. Ann Translati Med. 2020;8(22):1525\u20131525. doi:10.21037/atm-20-6909", "ArticleIdList": ["10.21037/atm-20-6909", "PMC7729308", "33313270"]}, {"Citation": "B\u00e4urle P, Suter A, Wormstall H. Safety and effectiveness of a traditional ginkgo fresh plant extract\u2013results from a clinical trial. Complem Med Res. 2009;16(3):156\u2013161. doi:10.1159/000213167", "ArticleIdList": ["10.1159/000213167", "19657199"]}, {"Citation": "Isah T. Rethinking Ginkgo biloba L.: medicinal uses and conservation. Pharmacog Rev. 2015;9(18):140. doi:10.4103/0973-7847.162137", "ArticleIdList": ["10.4103/0973-7847.162137", "PMC4557237", "26392712"]}, {"Citation": "Tao Y, Chen L, Yan J. Traditional uses, processing methods, phytochemistry, pharmacology and quality control of Dipsacus asper Wall. ex CB Clarke: a review. J Ethnopharmacol. 2020;258:112912. doi:10.1016/j.jep.2020.112912", "ArticleIdList": ["10.1016/j.jep.2020.112912", "32348843"]}, {"Citation": "Fujiwara H, Tabuchi M, Yamaguchi T, et al. A traditional medicinal herb Paeonia suffruticosa and its active constituent 1, 2, 3, 4, 6\u2010penta\u2010O\u2010galloyl\u2010\u03b2\u2010d\u2010glucopyranose have potent anti\u2010aggregation effects on Alzheimer\u2019s amyloid \u03b2 proteins in vitro and in vivo. J Neuroch. 2009;109(6):1648\u20131657. doi:10.1111/j.1471-4159.2009.06069.x", "ArticleIdList": ["10.1111/j.1471-4159.2009.06069.x", "19457098"]}, {"Citation": "Lv J, Jia H, Jiang Y, et al. Tenuifolin, an extract derived from tenuigenin, inhibits amyloid\u2010\u03b2 secretion in vitro. Acta Physiol. 2009;196(4):419\u2013425. doi:10.1111/j.1748-1716.2009.01961.x", "ArticleIdList": ["10.1111/j.1748-1716.2009.01961.x", "19208093"]}, {"Citation": "Yin Y, Huang L, Liu Y, et al. Effect of tanshinone on the levels of nitric oxide synthase and acetylcholinesterase in the brain of Alzheimer\u2019s disease rat model. Clin Investigat Med;2008. E248\u2013E257. doi:10.25011/cim.v31i5.4871", "ArticleIdList": ["10.25011/cim.v31i5.4871", "18980714"]}, {"Citation": "Wang R-N, Zhao H-C, Huang J-Y, et al. Challenges and strategies in progress of drug delivery system for traditional Chinese medicine Salviae Miltiorrhizae Radix et Rhizoma (Danshen). Chin Herbal Med. 2021;13(1):78\u201389. doi:10.1016/j.chmed.2020.08.001", "ArticleIdList": ["10.1016/j.chmed.2020.08.001", "PMC9476708", "36117766"]}, {"Citation": "Eckert GP. Traditional used plants against cognitive decline and Alzheimer disease. Front Pharmacol. 2010;1:138. doi:10.3389/fphar.2010.00138", "ArticleIdList": ["10.3389/fphar.2010.00138", "PMC3153012", "21833177"]}, {"Citation": "Fujiwara H, Iwasaki K, Furukawa K, et al. Uncaria rhynchophylla, a Chinese medicinal herb, has potent antiaggregation effects on Alzheimer\u2019s \u03b2\u2010amyloid proteins. J Neurosci Res. 2006;84(2):427\u2013433. doi:10.1002/jnr.20891", "ArticleIdList": ["10.1002/jnr.20891", "16676329"]}, {"Citation": "Xian Y-F, Lin Z-X, Zhao M, Mao -Q-Q, S-P I, Che C-T. Uncaria rhynchophylla ameliorates cognitive deficits induced by D-galactose in mice. Planta Med. 2011;77(18):1977\u20131983. doi:10.1055/s-0031-1280125", "ArticleIdList": ["10.1055/s-0031-1280125", "21858756"]}, {"Citation": "Uabundit N, Wattanathorn J, Mucimapura S, Ingkaninan K. Cognitive enhancement and neuroprotective effects of Bacopa monnieri in Alzheimer\u2019s disease model. J Ethnopharmac. 2010;127(1):26\u201331. doi:10.1016/j.jep.2009.09.056", "ArticleIdList": ["10.1016/j.jep.2009.09.056", "19808086"]}, {"Citation": "Banerjee S, Anand U, Ghosh S, et al. Bacosides from Bacopa monnieri extract: an overview of the effects on neurological disorders. Phytoth Res. 2021;35(10):5668\u20135679. doi:10.1002/ptr.7203", "ArticleIdList": ["10.1002/ptr.7203", "34254371"]}, {"Citation": "Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi A, Khani M. Salvia officinalis extract in the treatment of patients with mild to moderate Alzheimer\u2019s disease: a double blind, randomized and placebo\u2010controlled trial. J Clin Pharm Therapeut. 2003;28(1):53\u201359. doi:10.1046/j.1365-2710.2003.00463.x", "ArticleIdList": ["10.1046/j.1365-2710.2003.00463.x", "12605619"]}, {"Citation": "Ghorbani A, Esmaeilizadeh M. Pharmacological properties of Salvia officinalis and its components. J Tradit Complem Med. 2017;7(4):433\u2013440. doi:10.1016/j.jtcme.2016.12.014", "ArticleIdList": ["10.1016/j.jtcme.2016.12.014", "PMC5634728", "29034191"]}, {"Citation": "Akhondzadeh S, Noroozian M, Mohammadi M, Ohadinia S, Jamshidi A, Khani M. Melissa officinalis extract in the treatment of patients with mild to moderate Alzheimer\u2019s disease: a double blind, randomised, placebo controlled trial. J Neurol Neurosurg Psych. 2003;74(7):863\u2013866. doi:10.1136/jnnp.74.7.863", "ArticleIdList": ["10.1136/jnnp.74.7.863", "PMC1738567", "12810768"]}, {"Citation": "Soodi M, Naghdi N, Hajimehdipoor H, Choopani S, Sahraei E. Memory-improving activity of Melissa officinalis extract in na\u00efve and scopolamine-treated rats. Res Pharmac Sci. 2014;9(2):107.", "ArticleIdList": ["PMC4311288", "25657779"]}, {"Citation": "Vasudevan M, Parle M. Antiamnesic potential of Murraya koenigii leaves. Phytoth Res. 2009;23(3):308\u2013316. doi:10.1002/ptr.2620", "ArticleIdList": ["10.1002/ptr.2620", "18844259"]}, {"Citation": "Tan MA, Sharma N, An SSA. Multi-Target approach of Murraya koenigii leaves in treating neurodegenerative diseases. Pharmaceuticals. 2022;15(2):188. doi:10.3390/ph15020188", "ArticleIdList": ["10.3390/ph15020188", "PMC8880493", "35215300"]}, {"Citation": "Kim DH, Hyun SK, Yoon BH, et al. Gluco-obtusifolin and its aglycon, obtusifolin, attenuate scopolamine-induced memory impairment. J Pharmacol Sci. 2009;111(2):110\u2013116. doi:10.1254/jphs.08286FP", "ArticleIdList": ["10.1254/jphs.08286FP", "19834282"]}, {"Citation": "Kim DH, Yoon BH, Kim Y-W, et al. The seed extract of Cassia obtusifolia ameliorates learning and memory impairments induced by scopolamine or transient cerebral hypoperfusion in mice. J Pharmacol Sci. 2007;105(1):82\u201393. doi:10.1254/jphs.FP0061565", "ArticleIdList": ["10.1254/jphs.FP0061565", "17895591"]}, {"Citation": "Dhanasekaran M, Holcomb LA, Hitt AR, et al. Centella asiatica extract selectively decreases amyloid \u03b2 levels in hippocampus of Alzheimer\u2019s disease animal model. Phytoth Res. 2009;23(1):14\u201319. doi:10.1002/ptr.2405", "ArticleIdList": ["10.1002/ptr.2405", "19048607"]}, {"Citation": "Lai CS-W, Yu M-S, Yuen W-H, K-F S, Zee S-Y, Chang R-C-C. Antagonizing \u03b2-amyloid peptide neurotoxicity of the anti-aging fungus Ganoderma lucidum. Brain Res. 2008;1190:215\u2013224. doi:10.1016/j.brainres.2007.10.103", "ArticleIdList": ["10.1016/j.brainres.2007.10.103", "18083148"]}, {"Citation": "Joshi H, Parle M. Antiamnesic effects of Desmodium gangeticum in mice. Yakugaku Zasshi. 2006;126(9):795\u2013804. doi:10.1248/yakushi.126.795", "ArticleIdList": ["10.1248/yakushi.126.795", "16946593"]}, {"Citation": "M-S Y, Leung SK-Y, Lai S-W, et al. Neuroprotective effects of anti-aging oriental medicine Lycium barbarum against \u03b2-amyloid peptide neurotoxicity. Experim Gerontol. 2005;40(8\u20139):716\u2013727. doi:10.1016/j.exger.2005.06.010", "ArticleIdList": ["10.1016/j.exger.2005.06.010", "16139464"]}, {"Citation": "Tabuchi M, Yamaguchi T, Iizuka S, Imamura S, Ikarashi Y, Kase Y. Ameliorative effects of yokukansan, a traditional Japanese medicine, on learning and non-cognitive disturbances in the Tg2576 mouse model of Alzheimer\u2019s disease. J Ethnoph. 2009;122(1):157\u2013162. doi:10.1016/j.jep.2008.12.010", "ArticleIdList": ["10.1016/j.jep.2008.12.010", "19146938"]}, {"Citation": "Tohda C, Tamura T, Komatsu K. Repair of amyloid \u03b2 (25\u201335)-induced memory impairment and synaptic loss by a Kampo formula, Zokumei-to. Brain Res. 2003;990(1\u20132):141\u2013147. doi:10.1016/S0006-8993(03)03449-8", "ArticleIdList": ["10.1016/S0006-8993(03)03449-8", "14568338"]}, {"Citation": "Saxena G, Singh SP, Pal R, Singh S, Pratap R, Nath C. Gugulipid, an extract of Commiphora whighitii with lipid-lowering properties, has protective effects against streptozotocin-induced memory deficits in mice. Pharmacol Biochemist Behav. 2007;86(4):797\u2013805. doi:10.1016/j.pbb.2007.03.010", "ArticleIdList": ["10.1016/j.pbb.2007.03.010", "17477963"]}, {"Citation": "Gharibi A, Khalili M, Kiasalari Z, Hoseinirad M. The effect of Zingiber officinalis L. on learning and memory in rats. J Bas Clin Pathophysiol. 2013;2:2013\u20132014."}, {"Citation": "Vasudevan M, Parle M. Memory enhancing activity of Anwala churna (Emblica officinalis Gaertn.): an Ayurvedic preparation. Physiol Behav. 2007;91(1):46\u201354. doi:10.1016/j.physbeh.2007.01.016", "ArticleIdList": ["10.1016/j.physbeh.2007.01.016", "17343883"]}, {"Citation": "Singh H, Dhawan B. Neuropsychopharmacological effects of the Ayurvedic nootropic Bacopa monniera Linn.(Brahmi). Indian J Pharmacol. 1997;29(5):359."}, {"Citation": "Sharma R, Amin H, Prajapati P, Ruknuddin G. Therapeutic Vistas of Guduchi (Tinospora cordifolia): a medico-historical memoir. J Res Educ Ind Med. 2014;20:113\u2013128."}, {"Citation": "Rajakrishnan V, Viswanathan P, Rajasekharan K, Menon VP. Neuroprotective role of curcumin from Curcuma longa on ethanol\u2010induced brain damage. Phytoth Res. 1999;13(7):571\u2013574. doi:10.1002/(SICI)1099-1573(199911)13:7<571::AID-PTR494>3.0.CO;2-7", "ArticleIdList": ["10.1002/(SICI)1099-1573(199911)13:7<571::AID-PTR494>3.0.CO;2-7", "10548748"]}, {"Citation": "Karkada G, Shenoy K, Halahalli H, Karanth K. Nardostachys jatamansi extract prevents chronic restraint stress-induced learning and memory deficits in a radial arm maze task. J Nat Sci, Bio Med. 2012;3(2):125. doi:10.4103/0976-9668.101879", "ArticleIdList": ["10.4103/0976-9668.101879", "PMC3510905", "23225973"]}, {"Citation": "Vasundhara S, Hafsa A, Rajiv G. Memory enhancing effects of Ficus carica leaves in hexane extract on interoceptive behavioral models. Asian J Pharm Clin Res. 2013;6(3):109\u2013113."}, {"Citation": "Pramodinee D, Mahesh M, Niranjan D, Sankpala S. Memory enhancing activity of Cissampelos papiera in mice. Int J Pharm Sci. 2011;3:206\u2013211."}, {"Citation": "Roy C, Ghosh T, Guha D. The antioxidative role of Benincasa hispida on colchicine induced experimental rat model of Alzheimer\u2019s disease. Biogenic Amines. 2007;21(1/2):1."}, {"Citation": "Jyothi P, Kumara S. Central nervous system protection by Catharanthus roseus leaf extract in streptozotocin-induced diabetes in rat brain. J Pharmacog. 2012;3(2):63\u201366."}, {"Citation": "Carlini E. Plants and the central nervous system. Pharmacol Biochem Behav. 2003;75(3):501\u2013512. doi:10.1016/S0091-3057(03)00112-6", "ArticleIdList": ["10.1016/S0091-3057(03)00112-6", "12895668"]}, {"Citation": "Pradeep S, Prabhuswaminath SC, Reddy P, et al. Anticholinesterase activity of Areca Catechu: in vitro and in silico green synthesis approach in search for therapeutic agents against Alzheimer\u2019s disease. Fronti Pharmacol. 2022;13:1044248. doi:10.3389/fphar.2022.1044248", "ArticleIdList": ["10.3389/fphar.2022.1044248", "PMC9672481", "36408228"]}, {"Citation": "Kashyap P, Muthusamy K, Niranjan M, Trikha S, Kumar S. Sarsasapogenin: a steroidal saponin from Asparagus racemosus as multi target directed ligand in Alzheimer\u2019s disease. Steroids. 2020;153:108529. doi:10.1016/j.steroids.2019.108529", "ArticleIdList": ["10.1016/j.steroids.2019.108529", "31672628"]}, {"Citation": "Rai K, Murthy K, Karanth K, Nalini K, Rao M, Srinivasan K. Clitoria ternatea root extract enhances acetylcholine content in rat hippocampus. Fitoterapia. 2002;73(7\u20138):685\u2013689. doi:10.1016/S0367-326X(02)00249-6", "ArticleIdList": ["10.1016/S0367-326X(02)00249-6", "12490229"]}, {"Citation": "Cambay Z, Baydas G, Tuzcu M, Bal R. Pomegranate (Punica granatum L.) flower improves learning and memory performances impaired by diabetes mellitus in rats. Acta Physiol Hung. 2011;98(4):409\u2013420. doi:10.1556/APhysiol.98.2011.4.4", "ArticleIdList": ["10.1556/APhysiol.98.2011.4.4", "22173022"]}, {"Citation": "Polinsky RJ. Clinical pharmacology of rivastigmine: a new-generation acetylcholinesterase inhibitor for the treatment of Alzheimer\u2019s disease. Clin Therap. 1998;20(4):634\u2013647. doi:10.1016/S0149-2918(98)80127-6", "ArticleIdList": ["10.1016/S0149-2918(98)80127-6", "9737824"]}, {"Citation": "Razay G, Wilcock GK. Galantamine in Alzheimer\u2019s disease. Exp Rev Neurotherap. 2008;8(1):9\u201317. doi:10.1586/14737175.8.1.9", "ArticleIdList": ["10.1586/14737175.8.1.9", "18088197"]}, {"Citation": "Maelicke A, Hoeffle-Maas A, Ludwig J, et al. Memogain is a galantamine pro-drug having dramatically reduced adverse effects and enhanced efficacy. J Mol Neurosc. 2010;40:135\u2013137. doi:10.1007/s12031-009-9269-5", "ArticleIdList": ["10.1007/s12031-009-9269-5", "19669943"]}, {"Citation": "Williams P, Sorribas A, Howes M-JR. Natural products as a source of Alzheimer\u2019s drug leads. Nat Prod Rep. 2011;28(1):48\u201377. doi:10.1039/c0np00027b", "ArticleIdList": ["10.1039/c0np00027b", "PMC4917364", "21072430"]}, {"Citation": "Ha GT, Wong RK, Zhang Y. Huperzine a as potential treatment of Alzheimer\u2019s disease: an assessment on chemistry, pharmacology, and clinical studies. Chem Biodiv. 2011;8(7):1189\u20131204. doi:10.1002/cbdv.201000269", "ArticleIdList": ["10.1002/cbdv.201000269", "21766442"]}, {"Citation": "Nishteswar K, Joshi H, Karra RD. Role of indigenous herbs in the management of Alzheimer\u2019s disease. Anci Sci Life. 2014;34(1):3. doi:10.4103/0257-7941.150763", "ArticleIdList": ["10.4103/0257-7941.150763", "PMC4342646", "25737604"]}, {"Citation": "Amin H, Sharma R. Nootropic efficacy of satvavajaya chikitsa and ayurvedic drug therapy: a comparative clinical exposition. Internat J Yoga. 2015;8(2):109. doi:10.4103/0973-6131.158473", "ArticleIdList": ["10.4103/0973-6131.158473", "PMC4479887", "26170589"]}]}], "History": [{"Year": "2023", "Month": "11", "Day": "27"}, {"Year": "2024", "Month": "5", "Day": "3"}, {"Year": "2024", "Month": "5", "Day": "24", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "5", "Day": "24", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "5", "Day": "24", "Hour": "3", "Minute": "54"}, {"Year": "2024", "Month": "5", "Day": "19"}], "PublicationStatus": "epublish", "ArticleIdList": ["38784601", "PMC11114142", "10.2147/DNND.S452009", "452009"]}}]}